Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016)

Administered by Department of Veterans' Affairs

Legislation au F2016L00569 Not in force Legislative Instrument

Legislation content

Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016)

made under subsection 196B(3) of the

Veterans' Entitlements Act 1986

Compilation No. 1  

Compilation date:   18 September 2017

Includes amendments up to: Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017 (No. 58 of 2017) (F2017L01067)

The day of commencement of this Amendment Determination is 18 September 2017.

 

About this compilation

 

This compilation

This is a compilation of the Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016) that shows the text of the law as amended and in force on 18 September 2017.

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

 

 

 

Statement of Principles

concerning

BENIGN NEOPLASM OF THE EYE AND ADNEXA
(Balance of Probabilities)

(No. 42 of 2016)

The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans’ Entitlements Act 1986.

 

Dated 22 April 2016

 

 

 

 

 

 

 

 Contents

1 Name

2 Commencement

3 Authority

4 Revocation

5 Application

6 Definitions

7 Kind of injury, disease or death to which this Statement of Principles relates

8 Basis for determining the factors

9 Factors that must exist

10 Relationship to service

11 Factors referring to an injury or disease covered by another Statement of Principles

Schedule 1 - Dictionary

1 Definitions

 


1               Name

This is the Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016).

2               Commencement

 This instrument commences on 23 May 2016.

3               Authority

This instrument is made under subsection 196B(3) of the Veterans’ Entitlements Act 1986.

4               Revocation

The Statement of Principles concerning benign neoplasm of the eye and adnexa No. 34 of 2008, as amended, made under subsections 196B(3) and (8) of the VEA is revoked.

5               Application

This instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.

6               Definitions

The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.

7               Kind of injury, disease or death to which this Statement of Principles relates

(1)          This Statement of Principles is about benign neoplasm of the eye and adnexa and death from benign neoplasm of the eye and adnexa.

Meaning of benign neoplasm of the eye and adnexa

(2)          For the purposes of this Statement of Principles, benign neoplasm of the eye and adnexa means:

(a)          a non-malignant neoplastic proliferation of the cells of the eye classified according to site as conjunctiva, cornea, retina, choroid, ciliary body, lacrimal gland, lacrimal duct and orbit; and

(b)          excludes benign neoplasms of eyelids, optic nerve, meninges and orbital bone; lipoma, haemangioma, lymphangioma, melanocytic naevi, neurofibromatosis, retinal vasoproliferative tumour and ocular surface squamous dysplasia.

(3)          While benign neoplasm of the eye and adnexa attracts ICD10AM code D31, in applying this Statement of Principles the meaning of benign neoplasm of the eye and adnexa is that given in subsection (2).

(4)          For subsection (3), a reference to an ICD10AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD10AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 9781760070205.

Death from benign neoplasm of the eye and adnexa

(5)          For the purposes of this Statement of Principles, benign neoplasm of the eye and adnexa, in relation to a person, includes death from a terminal event or condition that was contributed to by the person’s benign neoplasm of the eye and adnexa.

Note: terminal event is defined in the Schedule 1 – Dictionary.

8               Basis for determining the factors

On the sound medicalscientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that benign neoplasm of the eye and adnexa and death from benign neoplasm of the eye and adnexa can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.

Note: relevant service is defined in the Schedule 1 – Dictionary.

9               Factors that must exist

At least one of the following factors must exist before it can be said that, on the balance of probabilities, benign neoplasm of the eye and adnexa or death from benign neoplasm of the eye and adnexa is connected with the circumstances of a person’s relevant service:

(1)          for papilloma of the conjunctiva only, acquiring persistent infection of the epithelium of the conjunctiva with a strain from the specified list of human papilloma virus (HPV) strains before the clinical onset of benign neoplasm of the eye and adnexa;

Note: specified list of human papilloma virus (HPV) strains is defined in the Schedule 1 - Dictionary.             

(2)          for schwannoma of the eye and adnexa only, having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the eye or orbit at least ten years before the clinical onset of benign neoplasm of the eye and adnexa;

Note: cumulative equivalent dose and schwannoma are defined in the Schedule 1 - Dictionary.             

(3)          inability to obtain appropriate clinical management for benign neoplasm of the eye and adnexa.

10           Relationship to service

(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.

(2)          The factor set out in subsection 9(3) applies only to material contribution to, or aggravation of, benign neoplasm of the eye and adnexa where the person’s benign neoplasm of the eye and adnexa was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

11           Factors referring to an injury or disease covered by another Statement of Principles

In this Statement of Principles:

(1)          if a factor referred to in section 9 applies in relation to a person; and

(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;

then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

 

 

Schedule 1 - Dictionary  

Note:  See Section 6

1               Definitions

     In this instrument:

                             benign neoplasm of the eye and adnexa—see subsection 7(2).

cumulative equivalent dose means the total dose of ionising radiation received by the particular organ or tissue from external exposure, internal exposure or both, apart from normal background radiation exposure in Australia, calculated in accordance with the methodology set out in Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.

Note 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.

Note 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.

                             MRCA means the Military Rehabilitation and Compensation Act 2004.

                             relevant service means:

(a)          eligible war service (other than operational service) under the VEA;

(b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or

(c)          peacetime service under the MRCA.

                               schwannoma means a benign neoplasm originating from Schwann cells of the myelin sheath of neurons of peripheral, cranial or autonomic nerves, comprising two types, neurilemomas and neurofibromas.

                               specified list of human papilloma virus (HPV) strains means HPV type 6, 11, 16, 18, 33 or 45.

                             terminal event means the proximate or ultimate cause of death and includes the following:

(a)           pneumonia;

(b)           respiratory failure;

(c)           cardiac arrest;

(d)           circulatory failure; or

(e)           cessation of brain function.

                             VEA means the Veterans' Entitlements Act 1986.

 

 

 Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history. 

Endnote 2—Abbreviation key

 

o = order(s)

ad = added or inserted

Ord = Ordinance

am = amended

orig = original

amdt = amendment

par = paragraph(s)/subparagraph(s)

c = clause(s)

    /subsubparagraph(s)

C[x] = Compilation No. x

pres = present

Ch = Chapter(s)

prev = previous

def = definition(s)

(prev…) = previously

Dict = Dictionary

Pt = Part(s)

disallowed = disallowed by Parliament

r = regulation(s)/rule(s)

Div = Division(s)

 

exp = expires/expired or ceases/ceased to have

reloc = relocated

    effect

renum = renumbered

F = Federal Register of Legislation

rep = repealed

gaz = gazette

rs = repealed and substituted

LA = Legislation Act 2003

s = section(s)/subsection(s)

LIA = Legislative Instruments Act 2003

Sch = Schedule(s)

(md) = misdescribed amendment can be given

Sdiv = Subdivision(s)

    effect

SLI = Select Legislative Instrument

(md not incorp) = misdescribed amendment

SR = Statutory Rules

    cannot be given effect

SubCh = SubChapter(s)

mod = modified/modification

SubPt = Subpart(s)

No. = Number(s)

underlining = whole or part not

 

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016)

 

26 April 2016

 

F2016L00569

23 May 2016

 

 

Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017 (No. 58 of 2017)

 

22 August 2017

 

F2017L01067

 

18 September 2017

 

 

 

Endnote 4—Amendment history

 

Provision affected

How affected

Schedule 1 – Dictionary – ' "cumulative equivalent dose"……'

rs. No. 58 of 2017

 

 

Overview

The Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016) was enacted to address the problem of benign neoplasms of the eye and adnexa, including death from such neoplasms, among veterans and members of the Australian Defence Force, and to establish the connection between these conditions and their relevant service under the Veterans' Entitlements Act 1986. This legislative instrument, made by the Repatriation Medical Authority under subsection 196B(3) of the Act, aims to provide clarity and guidance for veterans and members of the Defence Force making claims related to benign neoplasms of the eye and adnexa. The policy objective is to ensure that these individuals receive appropriate recognition and support for their service-related conditions. The Statement of Principles came into effect on 23 May 2016 and has since been amended to incorporate changes related to cumulative equivalent dose, as outlined in the Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017. This Statement of Principles applies to claims under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004.

Scope and Application

The Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016) applies to claims made under section 120B of the Veterans’ Entitlements Act 1986 (VEA) or section 339 of the Military Rehabilitation and Compensation Act 2004 (MRCA). This legislative instrument pertains specifically to benign neoplasm of the eye and adnexa, which includes non-malignant neoplastic proliferations of the cells of the eye, classified according to specific sites such as the conjunctiva, cornea, and retina, but excludes certain other benign neoplasms such as those of the eyelids and optic nerve. The Statement of Principles is applicable to veterans and members of the Australian Defence Force who have rendered relevant service, which includes eligible war service, defence service, or peacetime service as defined in the VEA and MRCA. The principles apply on the basis of medical-scientific evidence indicating a probable connection between benign neoplasm of the eye and adnexa and the relevant service, considering specific factors such as exposure to certain strains of human papilloma virus for papilloma of the conjunctiva and receipt of a significant dose of ionising radiation for schwannoma of the eye and adnexa. The Statement of Principles also considers the inability to obtain appropriate clinical management for benign neoplasm of the eye and adnexa. Any factors that refer to injuries or diseases covered by other Statements of Principles will apply in accordance with the terms of those respective Statements of Principles. The instrument commenced on 23 May 2016 and includes amendments up to the Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017 (No. 58 of 2017), which commenced on 18 September 2017.

Key Provisions

The main operative sections of the Statement of Principles concerning benign neoplasm of the eye and adnexa (Balance of Probabilities) (No. 42 of 2016) outline the determination by the Repatriation Medical Authority that benign neoplasm of the eye and adnexa, and death from such conditions, can be related to relevant service rendered by veterans or members of the Forces under the Veterans' Entitlements Act 1986, or members under the Military Rehabilitation and Compensation Act 2004. This Statement of Principles specifies that certain factors, such as persistent infection with certain human papilloma virus (HPV) strains for conjunctival papilloma or exposure to a cumulative equivalent dose of ionising radiation for schwannoma, must exist to establish a connection between the benign neoplasm and relevant service. The determination also includes definitions of key terms, such as 'benign neoplasm of the eye and adnexa' and 'terminal event', and sets out the circumstances in which factors referring to injuries or diseases covered by other Statements of Principles apply. The Statement of Principles imposes specific obligations on claimants. For instance, claimants must demonstrate that at least one of the specified factors exists and that this factor is related to their relevant service. This includes providing evidence of persistent infection with specified HPV strains for conjunctival papilloma or documented exposure to a cumulative equivalent dose of ionising radiation for schwannoma. Additionally, the inability to obtain appropriate clinical management for benign neoplasm of the eye and adnexa can also be a factor. The claimants must ensure that these factors are linked to their service to substantiate their claim. There are no specific offences, penalties, or civil/criminal consequences outlined within the Statement of Principles itself. However, the overarching legislation under which this Statement of Principles is made, the Veterans' Entitlements Act 1986, provides for potential penalties and consequences for fraudulent claims or misrepresentations. Under the Act, individuals who knowingly make a false or misleading statement in connection with a claim can be subject to penalties, including fines and imprisonment. The specific penalties can vary depending on the severity and intent behind the fraudulent activity, and are detailed within the broader provisions of the Veterans' Entitlements Act.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Commencement Provisions
Repeal & Amendment
Offence Provisions
Licensing & Registration

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.